Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
Titel:
Patient-reported outcomes in high-risk HR+ /HER2- early breast cancer patients treated with endocrine therapy with or without palbociclib within the randomized PENELOPEB study
Auteur:
García-Sáenz, José Angel Marmé, Frederik Untch, Michael Bonnefoi, Hervé Kim, Sung-Bae Bear, Harry Mc Carthy, Nicole Gelmon, Karen Martin, Miguel Kelly, Catherine M. Reimer, Toralf Toi, Masakazu Law, Ernest Bhattacharyya, Helen Gnant, Michael Makris, Andreas Seiler, Sabine Burchardi, Nicole Nekljudova, Valentina Loibl, Sibylle Rugo, Hope S.